PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

The boundary between science fiction and medical reality blurs as companies like Elon Musk's Neuralink make strides in ...

Confirmatory trials are essential in the case of Accelerated Approval to confirm that the drug continues to offer the ...

FDA supports CaaMTech's CT-4201 psilocin program for depression, advancing psychedelic therapy and clearing key regulatory ...

Neuralink Corp., Elon Musk’s brain-computer venture, and rivals like Science Corp. are making strides in technology that ...

"Receiving FDA approval to initiate this pivotal study marks a significant ... and beginning of Envoy Medical's clinical trial, the timing of and FDA's position related to expanding the clinical trial ...

(Reuters) -Billionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on ... had received clearance from the FDA for its first-in-human clinical trial, when it was already under ...

Luye Pharma Group has received approval ... to conduct clinical trials for LY03021, a new innovative antidepressant designed to treat Major Depressive Disorder. This novel drug, which targets ...

Companies such as Neuralink, led by Elon Musk, are developing these devices and have already received FDA approval to conduct human trials. The rapid integration of artificial intelligence in ...

Nilotinib, a drug approved by the US Food and Drug Administration ... The data were presented at the 17th Clinical Trials on Alzheimer’s Disease (CTAD) conference. Nilotinib is a tyrosine ...

The company's self-developed original new drug, Chiauranib ... stage small cell lung cancer, has been approved for phase III clinical trials. Extensive disease small cell lung cancer (ES-SCLC ...

The FDA has published ... underrepresented populations in clinical trials to help improve the data we have about patients who will use the medical products if approved.” The guidance is out ...